Heather Turner
2012 - Orexigen Therapeutics
In 2012, Heather Turner earned a total compensation of $1.3M as Senior Vice President, General Counsel and Secretary at Orexigen Therapeutics, a 45% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $222,000 |
|---|---|
| Option Awards | $655,795 |
| Salary | $370,000 |
| Other | $7,608 |
| Total | $1,255,403 |
Turner received $655.8K in option awards, accounting for 52% of the total pay in 2012.
Turner also received $222K in non-equity incentive plan, $370K in salary and $7.6K in other compensation.
Rankings
In 2012, Heather Turner's compensation ranked 5,240th out of 11,487 executives tracked by ExecPay. In other words, Turner earned more than 54.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,240 out of 11,487 | 54th |
Division Manufacturing | 1,835 out of 4,253 | 57th |
Major group Chemicals And Allied Products | 442 out of 1,203 | 63rd |
Industry group Drugs | 289 out of 925 | 69th |
Industry Pharmaceutical Preparations | 227 out of 700 | 68th |
Source: SEC filing on April 22, 2015.
Turner's colleagues
We found four more compensation records of executives who worked with Heather Turner at Orexigen Therapeutics in 2012.
2012
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
2012
Preston Klassen
Orexigen Therapeutics
Head of Global Contrave Program and Executive Vice President, Product Development
2012
Joseph Hagan
Orexigen Therapeutics
Chief Business and Financial Officer
2012
Mark Booth
Orexigen Therapeutics